Patients with Sjögren's syndrome frequently have pulmonary involvement, but the involvement of nodular pulmonary lesions, including pulmonary amyloidosis, is rare. Most cases of pulmonary amyloidosis involve multiple nodules; solitary pulmonary nodular amyloidosis, as an associated condition of Sjögren's syndrome, is very rare. In our report, we present the case of an 80-year-old female with Sjögren's syndrome who was incidentally found to have a small solitary pulmonary nodule. The nodule showed high fluorodeoxyglucose uptake and contained areas of calcification. Because the probability that the nodular lesion was malignant could not be excluded, the tumor was excised using a thoracoscopic procedure; the final diagnosis was pulmonary nodular amyloidosis. Although most cases of pulmonary amyloidosis involve multiple nodules, amyloidosis should be considered in the differential diagnosis for a solitary pulmonary nodule in patients with Sjögren's syndrome.
Introduction
Amyloidosis is defined as a condition in which abnormal proteins that are composed of amyloid fibrins are deposited in various tissues. This condition can occur with chronic inflammatory diseases, malignancies, and collagen diseases. Sjögren's syndrome often involves various lung diseases, such as interstitial lung disease, primary pulmonary lymphoma, and pleuritis; however, pulmonary thoracoscopic surgery was performed. The nodular lesion was quite firm on palpation and was excised with a wedge resection. Pathological examination revealed that this nodule was composed of deposits of homogeneously eosinophilic and congophilic material (Fig. 3) , which also remained congophilic following staining by the potassium permanganate method. Based on these pathological findings, pulmonary amyloidosis was diagnosed.
The post-operative course was uneventful, and the patient has been followed-up with no recurrence of pulmonary amyloidosis for two years.
Discussion and Conclusion
Sjögren's syndrome is a chronic inflammatory autoimmune disease resulting in the sicca syndrome, which is pathologically characterized by lymphocytic infiltration of the exocrine glands. 1) Various extraglandular organs and tissues, such as the lung, kidney, and small vasculature are also affected in Sjögren's syndrome. Strimlan et al reported that 31 (9.0%) of 343 patients with Sjögren's syndrome had pulmonary involvement. They described that the most common involvement was diffuse interstitial infiltrations (51.6%); other types of involvement included pleural effusions (16.1%), diffuse alveolar lesions (12.9%), and nodular lesions (3.2%). The nodular lesions were pseudolymphoma, malignant lymphoma, and pulmonary amyloidosis.
2) Therefore, the solitary pulmonary nodular amyloidosis as an associated condition of Sjögren's syndrome is very rare.
Most cases of pulmonary amyloidosis involve multiple pulmonary nodules. Solitary nodular amyloidosis in the lung has been rarely reported. Hara et al. summarized 45 cases of pulmonary amyloidosis with Sjögren's syndrome, and only 5 of those cases involved solitary amyloidosis. 3) Amyloidosis, which is characterized by extracellular deposits of amyloid material, can occur with chronic inflammatory diseases (e.g., rheumatoid arthritis, Crohn's disease, and tuberculosis). 4) Spencer classified pulmonary amyloidosis into 3 categories: tracheobronchial amyloidosis (Type-1), nodular parenchymal amyloidosis (Type-2), and diffuse parenchymal (interstitial/diffuse alveolar septal) amyloidosis (Type-3). 5) According to the Spencer classification of pulmonary amyloidosis, the present case was classified as Type-2 pulmonary amyloidosis. Although the definite mechanism of pulmonary nodular amyloidosis is not clear, amyloid deposits are reportedly associated with cellular infiltration of plasma cells around the nodule.
Based on a literature review, pulmonary amyloidosis nodules are 1-4 cm in diameter and are usually found incidentally on chest radiographs of asymptomatic patients with other diseases. It has been reported that pulmonary amyloidosis lesions occur more frequently in the inferior lobes. 6) Some reports have documented that pulmonary amyloidosis is often associated with calcification or cavitations within the nodule. 7, 8) Although these findings were found in our case, we decided to resect the nodule for diagnosis and treatment because the probability that the nodular lesion was malignant could not be excluded.
In general, high uptake on FDG PET suggests that the nodule contains active and proliferative lesions such as lung cancer, infiltration tumor, tuberculoma, and pulmonary mycosis. Furthermore, FDG is reported to accumulate in amyloidosis lesions, and this is useful for the evaluation of the disease. 9) This characteristic makes it quite difficult to distinguish pulmonary nodular amyloidosis from lung cancer radiologically. Thus, invasive procedures such as transbronchial or surgical lung biopsy are necessary to confirm the diagnosis of amyloidosis.
In conclusion, we report a rare case of pulmonary amyloidosis presenting as a solitary nodule in a patient with Sjögren's syndrome. Although most cases of pulmonary amyloidosis show multiple nodules, amyloidosis should be considered in the differential diagnosis for a solitary nodule in patients with Sjögren's syndrome.
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